HR 4114 United States House · 117th Congress

Allergy Testing Access Act of 2021

Summary

Allergy Testing Access Act of 2021 This bill requires equal coverage of two types of allergy tests under Medicaid and Medicare. Specifically, in vitro specific IgE tests (blood tests) and percutaneous tests (skin tests) must be treated equally with respect to (1) medical necessity or other coverage requirements, (2) frequency limits, and (3) allergen unit limits.

Issues: ✓ Healthcare

Bill status in committee 1 of 4 stages cleared

Introduction

Jun 2021

Committee Review

Floor Vote

President

Introduced Jun 24, 2021 Last action Jun 25, 2021

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Jun 25, 2021

Committee

Referred to the Subcommittee on Health.

lower

Jun 24, 2021

Committee

Referred to the Subcommittee on Health.

lower

Jun 24, 2021

Committee

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

lower

Jun 24, 2021

Introduced

Introduced in House

lower

1 primary · 27 co-sponsors